|Bid||10.00 x 900|
|Ask||50.45 x 800|
|Day's range||33.32 - 35.55|
|52-week range||10.72 - 79.75|
|Beta (5Y monthly)||1.22|
|PE ratio (TTM)||22.40|
|Earnings date||09 Feb 2022 - 14 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||82.22|
With its stock down 41% over the past three months, it is easy to disregard Prothena (NASDAQ:PRTA). However, stock...
The biotech sector has been in focus through 2021 as vaccine makers like Moderna (MRNA) BioNTech (BNTX), and other companies like Dynavax (DVAX), Prothena (PRTA) and Intellia (NTLA) put up an exemplary performance.
Prothena Corporation plc ( NASDAQ:PRTA ) shareholders might be concerned after seeing the share price drop 21% in the...